Showing results (91-100 of 332) with videos related to
Sort By:
Pageof 34
Haematologica|August 3, 2014
Reduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignanciesClaire Oudin, Patrice Chevallier, Sabine Furst, et al.Blood|February 24, 2016
Larger number of invariant natural killer T cells in PBSC allografts correlates with improved GVHD-free and progression-free survivalFlorent Malard, Myriam Labopin, Patrice Chevallier, et al.Cancer Medicine|February 2, 2022
Isatuximab monotherapy in patients with refractory T-acute lymphoblastic leukemia or T-lymphoblastic lymphoma: Phase 2 studyNicolas Boissel, Patrice Chevallier, Vadim Doronin, et al.European Journal of Haematology|June 19, 2012
Clofarabine-containing conditioning regimen for allo-SCT in AML/ALL patients: a survey from the Acute Leukemia Working Party of EBMTPatrice Chevallier, Myriam Labopin, Stefanie Buchholz, et al.Bulletin Du Cancer|July 28, 2023
[Creating a community of heads of department to meet hospital system challenges: First experience in haematology]Roch Houot, Jacques-Olivier Bay, Patrice Chevallier, et al.Research Square|June 22, 2026
Itacitinib plus calcineurin inhibitor-based therapy for prophylaxis of graft-versus-host disease: GRAVITAS-119 resultsNirav Shah, Hannah Choe, Nancy Hardy, et al.Journal of Hematology & Oncology|September 4, 2016
Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMTFrancesco Saraceni, Myriam Labopin, Norbert-Claude Gorin, et al.Bone Marrow Transplantation|June 10, 2021
A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host diseaseYngvar Fløisand, Mark A Schroeder, Patrice Chevallier, et al.Bone Marrow Transplantation|December 23, 2017
Deconditioning, fatigue and impaired quality of life in long-term survivors after allogeneic hematopoietic stem cell transplantationStéphanie Dirou, Arnaud Chambellan, Patrice Chevallier, et al.The Journal of Infectious Diseases|March 6, 2014
Long-lasting HHV-6 reactivation in long-term adult survivors after double umbilical cord blood allogeneic stem cell transplantationMarina Illiaquer, Florent Malard, Thierry Guillaume, et al.Pageof 34